Abstract:Abstract Background Krüppel-like factor 4 (KLF4) is a member of the zinc finger transcription factor family and plays an important role in cell proliferation, differentiation, apoptosis, embryonic development, organ formation, and tumor invasion. There is little research on the clinicopathological characteristics and KLF4 expression in non-small cell lung cancer (NSCLC). Methods We conducted a retrospective study to further explore the correlation between KLF4 expression and clinicopathological features of NSCLC by immunohistochemical staining. Results This study included 81 males (52.3%), 74 females (47.7%), and 101 (65.2%) ages <65, 54 (34.8%) ages ≥65 years. A total number of 127 cases (81.9%) were adenocarcinoma, 26 cases (16.8%) were squamous cell carcinoma, and 2 cases (1.3%) were large cell carcinoma. There were 140 patients (89.7%) in T1-T2 phase and 15 patients in T3-T4 phase; 130 patients (83.9%) in N0 phase and 25 patients (16.1%) in N1-N3 phase. There were no distant metastases in 154 patients (99.4%), and only 1 patient (0.6%) was in M1 phase. In terms of clinical stage, 142 patients (91.6%) in stage I-II and 13 patients (8.4%) in stage III-IV. The number of patients with smoking history was 40 (25.8%). KLF4 expression in NSCLC tissues was significantly decreased compared with normal lung tissues (P<0.001); KLF4 expression in adenocarcinoma was lower than that in normal lung tissues (P<0.001), while there was no significant difference in quamous cell carcinoma (P=0.314). Higher KLF4 expression was significantly associated with clinicopathological features of NSCLC such as squamous cell carcinoma (P<0.001), later T stage (T3-T4 stage) (P=0.013), lymph node metastasis (P=0.011), later clinical stage (III-IV stage) (P=0.001). KLF4 expression was not associated with age (P=0.082); there was no significant difference in KLF4 expression between male and female patients with adenocarcinoma (P=0.709). It was also found that KLF4 was positively correlated with Ki-67 expression in patients with adenocarcinoma (r=0.272, P=0.002). Conclusions Aboval all, the tumor suppressor gene KLF4 might become a potential biomarker and a new therapeutic target for lung cancer patients.

Nkx2-1: a Novel Tumor Biomarker of Lung Cancer

Research progress on relationship of NKX2-1 with lung disease

[Diagnosis Value of Serum NKX2-1 for Primary Lung Cancer].

Prognostic Biomarkers after Radiotherapy for Nonsmall Cell Lung Cancer Based on Bioinformatics Analysis

A Tropomyosin Receptor Kinase Family Protein, NTRK2 is a Potential Predictive Biomarker for Lung Adenocarcinoma

NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer.

The Prognostic Value of TTF-1/NKX2-1 in Lung Squamous Cell Carcinoma

Interplay Of Mkp-1 And Nrf2 Drives Tumor Growth And Drug Resistance In Non-Small Cell Lung Cancer

A Novel Neutrophil Extracellular Traps-Related Lncrna Signature Predicts Prognosis in Patients with Early-Stage Lung Adenocarcinoma

KLRK1 as a prognostic biomarker for lung adenocarcinoma cancer

Transcription Factor&nbsp;KLF4: A Potential Biomarker of Non-small Cell Lung Cancertranscription Factor&nbsp;KLF4: A Potential Biomarker of Non-small Cell Lung Cancer

Nptx1 is A Novel Epigenetic Regulation Gene and Associated with Prognosis in Lung Cancer

Identification of Thioredoxin-1 As a Biomarker of Lung Cancer and Evaluation of Its Prognostic Value Based on Bioinformatics Analysis

TC-1 (c8orf4) Enhances Aggressive Biologic Behavior in Lung Cancer Through the Wnt/β-catenin Pathway.

Kras(G12D) and Nkx2-1 Haploinsufficiency Induce Mucinous Adenocarcinoma of the Lung.

Identification ofLBX2as a novel causal gene of lung adenocarcinoma

An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma

Single cell transcriptomic analysis reveals tumor immune infiltration by NK cells gene signature in lung adenocarcinoma

Identification of NLE1/CDK1 Axis As Key Regulator in the Development and Progression of Non-Small Cell Lung Cancer

Neutrophils Recruited by NKX2-1 Suppression via Activation of CXCLs/CXCR2 Axis Promote Lung Adenocarcinoma Progression

Identification and Validation of LINC01322 As a Potential Prognostic Biomarker and Oncogene Promoting Tumor Progression in Lung Adenocarcinoma.